Laboratory evaluation demonstrates antibacterial potential of zinc oxide nanoparticles paired with piperacillin-tazobactam against multidrug-resistant pathogens, suggesting viable therapeutic options.
Nanotechnology offers exciting prospects against infectious agents, particularly multidrug resistance bacteria (MDR), which is the roaring concern of this era.Zinc oxide nanoparticles (ZnO-Nps) efficiently deliver therapeutic agents into living systems due to their biocompatibility and bioactivity, which make them highly effective against infectious pathogens.The present investigation was designed to investigate the impact of the ZnO-Nps in combination with the Piperacillin-Tazobactam (TZP) drug against MDR.TZP are beta-lactam antibiotics highly effective against Gram-positive and Gram-negative
No takes yet. Share an insight, caveat, or question.
Yu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: